Genmab A/S
AGONISTIC TNF RECEPTOR BINDING AGENTS
Last updated:
Abstract:
The present invention relates to binding agents binding to receptors of the TNF superfamily, in particular binding agents binding to at least two different receptors of the TNF superfamily, as well as to their use in medicine. The present invention further relates to nucleic acid molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits.
Status:
Application
Type:
Utility
Filling date:
8 Jan 2021
Issue date:
19 Aug 2021